247 related articles for article (PubMed ID: 29950347)
1. Quantitative Proteomic Analysis Identifies AHNAK (Neuroblast Differentiation-associated Protein AHNAK) as a Novel Candidate Biomarker for Bladder Urothelial Carcinoma Diagnosis by Liquid-based Cytology.
Lee H; Kim K; Woo J; Park J; Kim H; Lee KE; Kim H; Kim Y; Moon KC; Kim JY; Park IA; Shim BB; Moon JH; Han D; Ryu HS
Mol Cell Proteomics; 2018 Sep; 17(9):1788-1802. PubMed ID: 29950347
[TBL] [Abstract][Full Text] [Related]
2. Comparative Tissue Proteomics of Microdissected Specimens Reveals Novel Candidate Biomarkers of Bladder Cancer.
Chen CL; Chung T; Wu CC; Ng KF; Yu JS; Tsai CH; Chang YS; Liang Y; Tsui KH; Chen YT
Mol Cell Proteomics; 2015 Sep; 14(9):2466-78. PubMed ID: 26081836
[TBL] [Abstract][Full Text] [Related]
3. Bladder cancer-associated protein, a potential prognostic biomarker in human bladder cancer.
Moreira JM; Ohlsson G; Gromov P; Simon R; Sauter G; Celis JE; Gromova I
Mol Cell Proteomics; 2010 Jan; 9(1):161-77. PubMed ID: 19783793
[TBL] [Abstract][Full Text] [Related]
4. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
[TBL] [Abstract][Full Text] [Related]
5. Integrated Fourier Transform Infrared Imaging and Proteomics for Identification of a Candidate Histochemical Biomarker in Bladder Cancer.
Witzke KE; Großerueschkamp F; Jütte H; Horn M; Roghmann F; von Landenberg N; Bracht T; Kallenbach-Thieltges A; Käfferlein H; Brüning T; Schork K; Eisenacher M; Marcus K; Noldus J; Tannapfel A; Sitek B; Gerwert K
Am J Pathol; 2019 Mar; 189(3):619-631. PubMed ID: 30770125
[TBL] [Abstract][Full Text] [Related]
6. AHNAK is highly expressed and plays a key role in cell migration and invasion in mesothelioma.
Sudo H; Tsuji AB; Sugyo A; Abe M; Hino O; Saga T
Int J Oncol; 2014 Feb; 44(2):530-8. PubMed ID: 24253341
[TBL] [Abstract][Full Text] [Related]
7. Identification of aldolase A as a potential diagnostic biomarker for colorectal cancer based on proteomic analysis using formalin-fixed paraffin-embedded tissue.
Yamamoto T; Kudo M; Peng WX; Takata H; Takakura H; Teduka K; Fujii T; Mitamura K; Taga A; Uchida E; Naito Z
Tumour Biol; 2016 Oct; 37(10):13595-13606. PubMed ID: 27468721
[TBL] [Abstract][Full Text] [Related]
8. Clinical Proteomics for Meningioma: An Integrated Workflow for Quantitative Proteomics and Biomarker Validation in Formalin-Fixed Paraffin-Embedded Tissue Samples.
Mukherjee A; Ghosh S; Biswas D; Rao A; Shetty P; Epari S; Moiyadi A; Srivastava S
OMICS; 2022 Sep; 26(9):512-520. PubMed ID: 36036964
[TBL] [Abstract][Full Text] [Related]
9. Proteome-based classification of Nonmuscle Invasive Bladder Cancer.
Stroggilos R; Mokou M; Latosinska A; Makridakis M; Lygirou V; Mavrogeorgis E; Drekolias D; Frantzi M; Mullen W; Fragkoulis C; Stasinopoulos K; Papadopoulos G; Stathouros G; Lazaris AC; Makrythanasis P; Ntoumas K; Mischak H; Zoidakis J; Vlahou A
Int J Cancer; 2020 Jan; 146(1):281-294. PubMed ID: 31286493
[TBL] [Abstract][Full Text] [Related]
10. p16 INK4a overexpression and p16/Ki-67 dual labeling versus conventional urinary cytology in the evaluation of urothelial carcinoma.
Piaton E; Carré C; Advenier AS; Decaussin-Petrucci M; Mège-Lechevallier F; Lantier P; Granier G; Ruffion A
Cancer Cytopathol; 2014 Mar; 122(3):211-20. PubMed ID: 24302621
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of the urothelial cancer landscape.
Dressler FF; Diedrichs F; Sabtan D; Hinrichs S; Krisp C; Gemoll T; Hennig M; Mackedanz P; Schlotfeldt M; Voß H; Offermann A; Kirfel J; Roesch MC; Struck JP; Kramer MW; Merseburger AS; Gratzke C; Schoeb DS; Miernik A; Schlüter H; Wetterauer U; Zubarev R; Perner S; Wolf P; Végvári Á
Nat Commun; 2024 May; 15(1):4513. PubMed ID: 38802361
[TBL] [Abstract][Full Text] [Related]
12. Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine.
Kageyama S; Isono T; Iwaki H; Wakabayashi Y; Okada Y; Kontani K; Yoshimura K; Terai A; Arai Y; Yoshiki T
Clin Chem; 2004 May; 50(5):857-66. PubMed ID: 14764641
[TBL] [Abstract][Full Text] [Related]
13. A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma.
Bao Z; Zhang W; Dong D
Oncotarget; 2017 Feb; 8(6):10485-10497. PubMed ID: 28060759
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study.
Frantzi M; van Kessel KE; Zwarthoff EC; Marquez M; Rava M; Malats N; Merseburger AS; Katafigiotis I; Stravodimos K; Mullen W; Zoidakis J; Makridakis M; Pejchinovski M; Critselis E; Lichtinghagen R; Brand K; Dakna M; Roubelakis MG; Theodorescu D; Vlahou A; Mischak H; Anagnou NP
Clin Cancer Res; 2016 Aug; 22(16):4077-86. PubMed ID: 27026199
[TBL] [Abstract][Full Text] [Related]
15. Proteomic characterization of arsenic and cadmium exposure in bladder cells.
Chen YT; Ou Yang WT; Juang HH; Chen CL; Chen HW; Tsui KH; Chang YH; Tsai CH; Hsueh C; Liao WC
Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1():e8578. PubMed ID: 31499585
[TBL] [Abstract][Full Text] [Related]
16. IMP3 predicts aggressive superficial urothelial carcinoma of the bladder.
Sitnikova L; Mendese G; Liu Q; Woda BA; Lu D; Dresser K; Mohanty S; Rock KL; Jiang Z
Clin Cancer Res; 2008 Mar; 14(6):1701-6. PubMed ID: 18347170
[TBL] [Abstract][Full Text] [Related]
17. SH3BGRL3 Protein as a Potential Prognostic Biomarker for Urothelial Carcinoma: A Novel Binding Partner of Epidermal Growth Factor Receptor.
Chiang CY; Pan CC; Chang HY; Lai MD; Tzai TS; Tsai YS; Ling P; Liu HS; Lee BF; Cheng HL; Ho CL; Chen SH; Chow NH
Clin Cancer Res; 2015 Dec; 21(24):5601-11. PubMed ID: 26286913
[TBL] [Abstract][Full Text] [Related]
18. Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation.
Monteiro-Reis S; Leça L; Almeida M; Antunes L; Monteiro P; Dias PC; Morais A; Oliveira J; Henrique R; Jerónimo C
Eur J Cancer; 2014 Jan; 50(1):226-33. PubMed ID: 24100025
[TBL] [Abstract][Full Text] [Related]
19. Proteomic comparison between different tissue preservation methods for identification of promising biomarkers of urothelial bladder cancer.
Valdés A; Bitzios A; Kassa E; Shevchenko G; Falk A; Malmström PU; Dragomir A; Segersten U; Lind SB
Sci Rep; 2021 Apr; 11(1):7595. PubMed ID: 33828141
[TBL] [Abstract][Full Text] [Related]
20. [Value of CK20 immunocytochemistry as an adjuvant to urine liquid-based cytology in detection of urothelial carcinoma].
Li M; Li HX; Guo HQ; Zhao H; Zhao LL; Ma JH; Li CL; Cao J; Pan QJ
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):669-73. PubMed ID: 23159079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
